Press Release – New York, NY – August 6, 2020 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole bookrunner in an underwritten public offering of 15,789,474 shares of the common stock of Avinger Inc. (NASDAQ: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease (PAD), at a price of $0.38 per share. The offering was made pursuant to a registration statement on Form S-3 (No. 333-230124) which was previously filed with the Securities and Exchange Commission and declared effective on March 29, 2019.
The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Darrin Ocasio, and Avital Perlman and associate Jacob Tabman.
- Sichenzia Ross Ference Carmel LLP Represents BriaCell Therapeutics in $15 Million Public Offering - July 16, 2025
- Sichenzia Ross Ference Carmel LLP Represents 60 Degrees Pharmaceuticals in Public Offering of Up to $10 Million - July 15, 2025
- Sichenzia Ross Ference Carmel LLP Represents Viewbix in $4.5 Million Private Placement - July 15, 2025